Lentivirus-mediated knockdown of Krüppel-like factor 9 inhibits the growth of ovarian cancer

Archives of Gynecology and Obstetrics

Volumn 291, Issue 2, 2015, Pages 377-382

  Zhang, Qing Hua ^a   Dou, Hong Tao ^a   Tang, Yu Jie ^a   Su, Shan ^a   Liu, Pei Shu ^b  

^a Central Hospital of Zibo   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Cell proliferation; KLF9; Lentivirus; Ovarian cancer

Indexed keywords

KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 9; UNCLASSIFIED DRUG; KLF9 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE G0 PHASE; CELL PROLIFERATION; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN TISSUE; LENTIVIRINAE; MOUSE; NONHUMAN; OVARY CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR XENOGRAFT; UPREGULATION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CELL CYCLE CHECKPOINT; CELL SURVIVAL; GENE SILENCING; GENETICS; MALE; NUDE MOUSE; OVARY TUMOR; PATHOLOGY;

ANIMALS; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LENTIVIRUS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; OVARIAN NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

EID: 84929072999     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-014-3405-3     Document Type: Article

References (20)

1. Foley OW, Rauh-Hain JA, Del CM (2013) Recurrent epithelial ovarian cancer: an update on treatment. Oncology (Williston Park) 27:288–294 (discussion 298)
2. Ahmed N, Stenvers KL (2013) Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research. Front Oncol 3:256
3. Kaczynski J, Cook T, Urrutia R (2003) Sp1- and Kruppel-like transcription factors. Genome Biol 4:206
4. Wieschaus E, Nusslein-Volhard C, Kluding H (1984) Kruppel, a gene whose activity is required early in the zygotic genome for normal embryonic segmentation. Dev Biol 104:172–186
5. McConnell BB, Yang VW (2010) Mammalian Kruppel-like factors in health and diseases. Physiol Rev 90:1337–1381
6. Pearson R, Fleetwood J, Eaton S, Crossley M, Bao S (2008) Kruppel-like transcription factors: a functional family. Int J Biochem Cell Biol 40:1996–2001
7. Lebrun C, Avci HX, Wehrle R, Doulazmi M, Jaudon F, Morel MP, Rivals I, Ema M, Schmidt S, Sotelo C, Vodjdani G, Dusart I (2013) Klf9 is necessary and sufficient for Purkinje cell survival in organotypic culture. Mol Cell Neurosci 54:9–21
8. Simmons CD, Pabona JM, Heard ME, Friedman TM, Spataro MT, Godley AL, Simmen FA, Burnett AF, Simmen RC (2011) Kruppel-like factor 9 loss-of-expression in human endometrial carcinoma links altered expression of growth-regulatory genes with aberrant proliferative response to estrogen. Biol Reprod 85:378–385
9. Ying M, Sang Y, Li Y, Guerrero-Cazares H, Quinones-Hinojosa A, Vescovi AL, Eberhart CG, Xia S, Laterra J (2011) Kruppel-like family of transcription factor 9, a differentiation-associated transcription factor, suppresses Notch1 signaling and inhibits glioblastoma-initiating stem cells. Stem Cells 29:20–31
10. Wei D, Kanai M, Jia Z, Le X, Xie K (2008) Kruppel-like factor 4 induces p27Kip1 expression in and suppresses the growth and metastasis of human pancreatic cancer cells. Cancer Res 68:4631–4639
11. Wang X, Zhao J (2007) KLF8 transcription factor participates in oncogenic transformation. Oncogene 26:456–461
12. Dong Z, Yang L, Lai D (2013) KLF5 strengthens drug resistance of ovarian cancer stem-like cells by regulating survivin expression. Cell Prolif 46:425–435
13. Jares P, Colomer D, Campo E (2007) Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat Rev Cancer 7:750–762
14. Musgrove EA, Caldon CE, Barraclough J, Stone A, Sutherland RL (2011) Cyclin D as a therapeutic target in cancer. Nat Rev Cancer 11:558–572
15. Chen C, Chang YC, Lan MS, Breslin M (2013) Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways. Int J Oncol 42:1113–1119
16. Xu YY, Wu HJ, Ma HD, Xu LP, Huo Y, Yin LR (2013) MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1. FEBS J 280:3768–3779
17. Jiao J, Huang L, Ye F, Shi M, Cheng X, Wang X, Hu D, Xie X, Lu W (2013) Cyclin D1 affects epithelial-mesenchymal transition in epithelial ovarian cancer stem cell-like cells. Onco Targets Ther 6:667–677
18. Liu Y, Wen JK, Dong LH, Zheng B, Han M (2010) Kruppel-like factor (KLF) 5 mediates cyclin D1 expression and cell proliferation via interaction with c-Jun in Ang II-induced VSMCs. Acta Pharmacol Sin 31:10–18
19. Zammarchi F, Morelli M, Menicagli M, Di Cristofano C, Zavaglia K, Paolucci A, Campani D, Aretini P, Boggi U, Mosca F, Cavazzana A, Cartegni L, Bevilacqua G, Mazzanti CM (2011) KLF4 is a novel candidate tumor suppressor gene in pancreatic ductal carcinoma. Am J Pathol 178:361–372
20. Persons DA (2010) Lentiviral vector gene therapy: effective and safe? Mol Ther 18:861–862